Concerns raised about high levels of microclots in long-haul COVID-19 patients undergoing testing.
-
Dr. Robin Rose expresses alarm over abnormal inflammatory markers and high microthrombi levels in long-haul COVID-19 patients. • 0:04
-
Dr. Rose highlights the disturbing findings of 3.5 to 4 out of 4 grade microthrombi in tested patients. • 2:13
-
Control group patients also show concerning levels of microclots, indicating a broader issue. • 2:55
-
Further research and work are needed to address the implications of these findings. • 3:03
Potential link between vaccines and elevated microclots in individuals without symptoms raises concerns.
-
Control group without symptoms showed elevated microclots, indicating underlying issues. • 3:41
-
Study in 2022 found extensive fibrin amyloid microclots in patients with long COVID. • 4:51
-
Addition of Spike protein to plasma induced clot formation, resistant to breakdown. • 6:22
-
Circulating Spike proteins post-vaccination may increase risk of clotting. • 7:12
Potential link between vaccines and microclots observed during blood filtration process.
-
Unusual fibrous clots observed during blood filtration process in patients. • 7:54
-
Microclotting and amyloid structures seen in patients with long covid, regardless of vaccination status. • 9:26
-
Importance of investigating abnormal protein patterns in blood to understand disease development. • 10:06
-
Urgent need for scientific community to address and clarify potential implications of observed patterns in patients. • 10:14
-
Access full congress for more information on recent research findings and discussions. • 10:30